Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Invested Capital (2019 - 2023)

Historic Return on Invested Capital for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to 31.92%.

  • Dna X's Return on Invested Capital rose 327200.0% to 31.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.92%, marking a year-over-year increase of 327200.0%. This contributed to the annual value of 4.06% for FY2024, which is 40800.0% down from last year.
  • Latest data reveals that Dna X reported Return on Invested Capital of 31.92% as of Q3 2025, which was up 327200.0% from 25.61% recorded in Q2 2025.
  • In the past 5 years, Dna X's Return on Invested Capital registered a high of 31.92% during Q3 2025, and its lowest value of 7.02% during Q4 2024.
  • Over the past 5 years, Dna X's median Return on Invested Capital value was 0.71% (recorded in 2022), while the average stood at 2.16%.
  • As far as peak fluctuations go, Dna X's Return on Invested Capital tumbled by -70300bps in 2024, and later skyrocketed by 327200bps in 2025.
  • Quarter analysis of 5 years shows Dna X's Return on Invested Capital stood at 2.42% in 2021, then skyrocketed by 70bps to 0.71% in 2022, then skyrocketed by 101bps to 0.01% in 2023, then tumbled by -66017bps to 7.02% in 2024, then surged by 555bps to 31.92% in 2025.
  • Its last three reported values are 31.92% in Q3 2025, 25.61% for Q2 2025, and 9.01% during Q1 2025.